Rekha Johnson is an accomplished professional with extensive experience in Clinical Quality and Compliance within the pharmaceuticals sector. Currently serving as Clinical Quality Lead at Debiopharm since January 2023, Rekha focuses on ensuring trial activities meet quality requirements. Previously, Rekha held significant roles at Versantis, including Compliance Lead and Quality Assurance Lead, contributing to the establishment of the company's Quality Management System. Additional experience includes positions at Widler & Schiemann AG as Associate Partner, leading projects in Quality and Risk Management, and roles at Takeda Pharmaceuticals, Arena Pharmaceuticals, DePuy Synthes, Roche Diagnostics, F. Hoffman La Roche, and Bristol-Myers Squibb in various capacities related to clinical study management and quality assurance. Academic credentials include a D.Phil. in Nanotechnology from Oxford University, an MBA from Edinburgh Business School, and a Graduate Diploma in Law from the College of Law in London.